1. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate;Augeron;Cancer Res.,1984
2. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function;Badger;J. Pharmacol. Exp. Ther.,1996
3. Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agents;Boudoulas;Ther. Drug Monit.,1996
4. Induction of differentiation in HL-60 leukemia cells: a cell cycle dependent all-or-none event;Boyd;Leukemia Res.,1984
5. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL-60;Breitman;Cancer Res.,1990